Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 McKesson EuropeArjo AB (publ)EBOS GroupParagon CareSinopharm Group
SymbolOTCMKTS:CAKFYOTCMKTS:ARRJFASX:EBOASX:PGCOTCMKTS:SHTDY
Price Information
Current Price$6.25$7.38N/AN/A$14.89
52 Week RangeN/AHoldN/AN/AN/A
MarketRank™
Overall Score0.50.20.80.80.6
Analysis Score0.00.00.00.00.0
Community Score2.61.02.52.13.0
Dividend Score0.00.01.71.70.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AHoldN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapN/AN/AN/AN/AN/A
BetaN/AN/AN/AN/AN/A
Average Volume475N/AN/AN/A51,801
Sales & Book Value
Annual RevenueN/AN/A$9.04 billion$226.14 millionN/A
Price / SalesN/AN/A0.000.00N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/A12.243.52N/A
Book ValueN/AN/AA$8.46 per shareA$0.35 per shareN/A
Price / BookN/AN/A0.000.00N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AA$1.07A($0.22)N/A
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AA$0.70A$0.02N/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A65.48%N/A N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A60.95%97.30%N/A
Current RatioN/AN/A1.13%1.40%N/A
Quick RatioN/AN/A0.72%0.74%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees26,3296,2143,700400108,316
Shares OutstandingN/AN/A164.14 million337.88 millionN/A
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Coronavirus: Latest on COVID-19 from around the world - Monday, April 12Coronavirus: Latest on COVID-19 from around the world - Monday, April 12
newshub.co.nz - April 11 at 7:04 PM
Sinopharms protein-based Covid-19 vaccine candidate gets China clinical trial nodSinopharm's protein-based Covid-19 vaccine candidate gets China clinical trial nod
entornointeligente.com - April 10 at 8:33 AM
Drug regulator in turmoilDrug regulator in turmoil
sundaytimes.lk - April 4 at 3:42 AM
Sinovac – Coronavirus latest: Sinopharm and Sinovac vaccine data show efficacy, WHO saysSinovac – Coronavirus latest: Sinopharm and Sinovac vaccine data show efficacy, WHO says
fintechzoom.com - March 31 at 2:19 PM
Why China is finally including the elderly in its Covid-19 vaccine programmeWhy China is finally including the elderly in its Covid-19 vaccine programme
scmp.com - March 30 at 1:14 PM
Coronavirus live news: France ICU cases climbing rapidly; US concern over WHO Covid origins reportCoronavirus live news: France ICU cases climbing rapidly; US concern over WHO Covid origins report
theguardian.com - March 29 at 10:14 AM
Chinese COVID-19 vaccines have neutralizing effect on mutant strains found in South Africa, UKChinese COVID-19 vaccines have neutralizing effect on mutant strains found in South Africa, UK
globaltimes.cn - March 28 at 9:44 AM
Scandal over COVID vaccine trial at Peruvian universities prompts outrageScandal over COVID vaccine trial at Peruvian universities prompts outrage
nature.com - March 26 at 5:40 PM
Coronavirus live news: Germany could face 100,000 cases a day, expert warns; EMA approves Halix vaccine factoryCoronavirus live news: Germany could face 100,000 cases a day, expert warns; EMA approves Halix vaccine factory
theguardian.com - March 26 at 12:39 PM
Doubts overshadow China’s pledge to vaccinate developing countriesDoubts overshadow China’s pledge to vaccinate developing countries
finance.yahoo.com - March 24 at 8:48 AM
Doubts overshadow Beijing’s pledge to vaccinate the developing worldDoubts overshadow Beijing’s pledge to vaccinate the developing world
finance.yahoo.com - March 23 at 10:47 PM
Covid-19 Mutants Haunt Medical ExpectsCovid-19 Mutants Haunt Medical Expects
zimeye.net - March 23 at 7:46 AM
The Latest: Bulgaria issues 10-day nationwide lockdownThe Latest: Bulgaria issues 10-day nationwide lockdown
washingtontimes.com - March 18 at 1:10 PM
UAE offers third shot of Chinese vaccine in some casesUAE offers third shot of Chinese vaccine in some cases
finance.yahoo.com - March 17 at 2:54 PM
Timeline: Tracking Latin Americas Road to VaccinationTimeline: Tracking Latin America's Road to Vaccination
as-coa.org - March 15 at 7:58 PM
Producer studies vaccine efficacy on mutation with additional third-dose injectionProducer studies vaccine efficacy on mutation with additional third-dose injection
globaltimes.cn - March 15 at 8:56 AM
Early Adopter U.A.E. Starts Giving Third Dose of Sinopharm Vaccine Amid Efficacy ConcernsEarly Adopter U.A.E. Starts Giving Third Dose of Sinopharm Vaccine Amid Efficacy Concerns
wsj.com - March 13 at 6:54 PM
U.A.E. Giving Third Shot of Sinopharm Vaccine to SomeU.A.E. Giving Third Shot of Sinopharm Vaccine to Some
wsj.com - March 12 at 9:59 PM
Timeline: Latin America’s Road to Get VaccinatedTimeline: Latin America’s Road to Get Vaccinated
as-coa.org - March 5 at 9:30 PM
Sinopharm jab use for people over 60 allowedSinopharm jab use for people over 60 allowed
dawn.com - March 5 at 9:30 PM
Diplomatic corp among new priority group to get jabsDiplomatic corp among new priority group to get jabs
khmertimeskh.com - March 5 at 11:30 AM
The Latest: EU official: No AstraZeneca exports to AustraliaThe Latest: EU official: No AstraZeneca exports to Australia
omaha.com - March 4 at 12:47 PM
China donates 50,000 doses of Sinopharm vaccine to LebanonChina donates 50,000 doses of Sinopharm vaccine to Lebanon
zawya.com - March 3 at 9:14 AM
Duterte awaits emergency use approval of Sinopharm vaccineDuterte awaits emergency use approval of Sinopharm vaccine
mb.com.ph - March 3 at 9:14 AM
Coronavirus latest: Thai PM orders vaccine passport studyCoronavirus latest: Thai PM orders 'vaccine passport' study
asia.nikkei.com - March 2 at 9:00 AM
DateCompanyBrokerageAction
2/25/2021Arjo AB (publ)SEB EquitiesUpgrade
1/27/2021Arjo AB (publ)SEB Equity ResearchDowngrade
1/25/2021Arjo AB (publ)Pareto SecuritiesDowngrade
1/20/2021Arjo AB (publ)Nordea Equity ResearchDowngrade
3/19/2020Sinopharm GroupThe Goldman Sachs GroupUpgrade
(Data available from 4/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.